The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 11 beta -arylsteroids of formula II: wherein R1, R6, R8, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of fibroids, en…
The invention is directed to 17 beta -nitro-11 beta -arylsteroids of formula I: wherein R1, R6, R7, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of f…
The invention is directed to 17 beta -nitro-11 beta -arylsteroids of formula I: wherein R1, R6, R7, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of f…
The invention is directed to 17 beta -nitro-11 beta -arylsteroids of formula I: wherein R1, R6, R7, R12 and X are as defined by the specification. The compounds exhibit potent antiprogestational activity and are useful in the treatment of f…